| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.053 | 0.8 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |